
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[NVO] Novo Nordisk - Time Machine
Data updated 2025-Apr-22 (Tuesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
Historical Summary: 2025-Apr-22 Tuesday
Open | $59.01 | High | $60.18 +1.98% |
---|---|---|---|
Close | $59.91 | Low | $58.92 -0.15% |
Volume | 11.7 Million 1.16x | Volatility | 2.14% |
Change |
+$1.58
+2.71%
|
Streak | ↑ 2 days +3.15% |
20d SMA | $65.31 -8.3% | 50d SMA | $76.00 -21.2% | 100d SMA | $84.58 -29.2% | 200d SMA | $104.68 -42.8% |
RSI | 35 | MACD | -0.07 | ADX | 40.6 | Stochastic Oscillator | 13.8 19.4 |
CCI | -102.8 | ATR | 3.09 | OBV | 319 Million | Chaikin A/D | 896 Million |
Choose view type
Daily Performance for Novo Nordisk. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Max Chart Timespan
Max Chart Timespan
Note: Performance over Key Timeperiods for Novo Nordisk up to close of 2025-Apr-22 at $59.91
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
-9.31%
|
-9.2%
|
+5.1%
|
15.7%
|
-1.4%
|
-1.0%
|
1.16x
|
02 Trailing 10-days
|
|
-5.86%
|
-10.2%
|
+5.1%
|
17.1%
|
-3.7%
|
-3.7%
|
1.17x
|
03 Trailing 20-days
|
|
-20.47%
|
-21.2%
|
+5.1%
|
33.4%
|
-8.3%
|
-8.8%
|
1.18x
|
04 Trailing 30-days
|
|
-24.12%
|
-27.4%
|
+5.1%
|
44.9%
|
-13.7%
|
-12.9%
|
1.05x
|
05 Trailing 50-days
|
|
-30.68%
|
-36.1%
|
+5.1%
|
64.6%
|
-21.2%
|
-18.8%
|
1.01x
|
06 Trailing 100-days
|
|
-42.98%
|
-46.8%
|
+5.1%
|
97.4%
|
-29.2%
|
-28.5%
|
1.31x
|
07 Trailing 200-days
|
|
-56.86%
|
-58.3%
|
+5.1%
|
152.1%
|
-42.8%
|
-36.9%
|
1.09x
|
08 Month-to-date
|
|
-13.72%
|
-14.4%
|
+5.1%
|
22.8%
|
|
|
|
09 Quarter-to-date
|
|
-13.72%
|
-14.4%
|
+5.1%
|
22.8%
|
|
|
|
10 Year-to-date
|
|
-30.35%
|
-36.1%
|
+5.1%
|
64.6%
|
|
|
|
11 Trailing 52-weeks
|
|
-52.17%
|
-59.6%
|
+5.1%
|
159.9%
|
|
|
|
Performance Benchmarks from 2025-Apr-22 for Novo Nordisk:
Related to Novo Nordisk
Information for Novo Nordisk
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine Currently Viewing
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-22 on Google
SEC Reports : Quarterly reports around 2025-Apr-22 on SEC Edgar
Compare Novo Nordisk with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Novo Nordisk
Industry : Pharmaceuticals industry performance which includes Novo Nordisk